Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

NCT03760952 is registered in ClinicalTrials.gov with Immatics US, Inc. as lead sponsor.

NCT NCT03760952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03760952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling
Lead sponsor
Immatics US, Inc.
Phase
Observational
Overall status
Completed
Start date
February 26, 2019
Completion date
November 15, 2022
Enrollment
242 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adult solid tumor, neoplasms, recurrent cancer, refractory cancer